Rhumbline Advisers Concert Pharmaceuticals, Inc. Transaction History

Rhumbline Advisers

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$3.77 - $5.24 $165,725 - $230,345	-43,959 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$4.86 - $13.07 $8,553 - $23,003	-1,760 Reduced 3.85%	43,959 $219,000
Q4 2020 Feb 10, 2021	BUY	$9.48 - $12.84 $58,899 - $79,774	6,213 Added 15.73%	45,719 $578,000
Q3 2020 Nov 12, 2020	SELL	$8.67 - $10.82 $54,699 - $68,263	-6,309 Reduced 13.77%	39,506 $388,000
Q2 2020 Aug 13, 2020	BUY	$7.8 - $11.52 $42,634 - $62,968	5,466 Added 13.55%	45,815 $456,000
Q1 2020 May 06, 2020	BUY	$5.98 - $13.09 $36,806 - $80,568	6,155 Added 18.0%	40,349 $357,000
Q4 2019 Feb 05, 2020	BUY	$5.71 - $9.22 $1,199 - $1,936	210 Added 0.62%	34,194 $315,000
Q3 2019 Oct 23, 2019	BUY	$5.88 - $12.35 $17,628 - $37,025	2,998 Added 9.68%	33,984 $200,000
Q2 2019 Aug 14, 2019	BUY	$9.44 - $13.12 $2,293 - $3,188	243 Added 0.79%	30,986 $372,000
Q1 2019 May 01, 2019	SELL	$12.07 - $17.54 $6,252 - $9,085	-518 Reduced 1.66%	30,743 $371,000
Q4 2018 Jan 31, 2019	BUY	$11.25 - $16.17 $104,771 - $150,591	9,313 Added 42.43%	31,261 $392,000
Q3 2018 Nov 07, 2018	BUY	$12.82 - $17.88 $3,987 - $5,560	311 Added 1.44%	21,948 $326,000
Q2 2018 Aug 06, 2018	BUY	$16.83 - $21.66 $69,406 - $89,325	4,124 Added 23.55%	21,637 $364,000
Q1 2018 May 02, 2018	BUY	$19.24 - $28.03 $5,098 - $7,427	265 Added 1.54%	17,513 $401,000
Q4 2017 Feb 09, 2018	SELL	$13.96 - $29.05 $44,672 - $92,960	-3,200 Reduced 15.65%	17,248 $446,000
Q3 2017 Nov 06, 2017	BUY	$13.91 - $15.31 $284,431 - $313,058	20,448	20,448 $302,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.